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Background: Recently, biological therapies for early intervention of degenerative disc disease have been
introduced and developed; however, a functional animal model that mimics slowly progressive disc degeneration
of humans does not exist. The objective of this study was to establish a slowly progressive and reproducible
intervertebral disc (IVD) degeneration model.
Methods: The subchondral bone adjacent to the lumbar IVDs (L3/4 and L5/6) of ten rhesus monkeys was randomly
injected with 4 ml bleomycin solution (1.5 mg/ml), or 4 ml phosphate buffer saline (PBS) per segment as control,
respectively. The degenerative process was investigated by using radiography and T1ρ MR imaging at 1, 3, 6, 9, 12
and 15 months postoperatively. Histological scoring, Sulfated Glycosaminoglycans (GAGs) analysis and real-time PCR
were performed at 15 months. The correlation between histological score, GAGs and T1ρ values were also analyzed.
Results: The results showed that the mean T1ρ values of nucleus pulposus (NP) and annulus fibrosus (AF) in the
bleomycin group significantly decreased after 3 and 6 months respectively, followed by slowly decrease until at
15 months. At 15 months, the histological scores was significantly higher, and the GAGs of NP was significantly
lower in the bleomycin group, compared with the control group (P < 0.05). The results of real-time PCR revealed a
significant increase in matrix metalloprotease (MMP)-3, A disintegrin and metalloproteinase with thrombospondin
motifs (ADAMTS)-5, tumor necrosis factor α, interleukin-1β, interleukin-6 expressions, transforming growth factor
(TGF-β1) and marked reduction in aggrecan, type II collagen, von willebrand factor (vWF) expressions at the mRNA
levels in the bleomycin group. Spearman correlation analysis showed a strong positive correlation between GAGs
and T1ρ values of NP (r =0.740, P < 0.01), and a significant inverse correlation between histological score and T1ρ
values of NP and AF (r = −0.761, r = −0.729, respectively, P < 0.01).
Conclusions: Injection of bleomycin into the subchondral bone adjacent to the lumbar IVDs of rhesus monkeys
can results in mild, slowly progressive disc degeneration, which mimics the onset of human disc degeneration.
T1ρ MR imaging is an effective and noninvasive technique for assessment of early stage disc degeneration.
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Intervertebral disc (IVD) degeneration,which is an epi-
demic human condition with a major socioeconomic im-
pact, is believed to be a main cause of low back pain [1].
However, a clear understanding of the basic mechanisms
of disease pathogenesis and specific therapeutic agents is
still limited [2]. An experimental animal model of hu-
man IVD degeneration is needed. It is well known that
IVD is the largest avascular structure in the human body
that has limit the capacity for regeneration. Although
there are several animal models of experimental disc de-
generation that have been developed, which including
spontaneous degeneration models [3], annulus fibrosus
injury models [4], and chemically induced models et al.
[5], these methods could not model the slowly ischemic
and progressive disc degeneration of human beings ef-
fectively. Although the needle puncture methods have
been recently developed and used to induce disc degen-
eration models to test the effectiveness of new therapies
for reversing IVD degeneration [4], this method induces
to IVD degeneration through direct injury, which is not
easy to control the degenerative process. Furthermore,
these models are not suitable for the studies related to bio-
logical treatment of IVD degeneration to some extent.
The nutritional pathways that into the nucleus pulposus
of human intervertebral discs are mainly by diffusion
through the central portion of the end-plate from these
marrow space cartilage contacts and diffusion through the
annulus fibrosus from the surrounding vessels [6]. An
alternation of the nutrient pathway is considered as one
of the main causes of IVD degeneration [7]. Bleomycin,
which have been used as sclerosing agents, has proved to
be safe and effective in the treatment of vascular malfor-
mations of the head and neck [8,9]. Intralesionally injected
bleomycin brings the drug into direct contact with the
endothelial lining and destroys the endothelial cells, result-
ing in sclerostenosis of the lumen and leading to narrow-
ing or occlusion of the vessels [10].
The purpose of this study was to establish an early is-
chemic, progressive, and reproducible IVD degeneration
model induced by injection of bleomycin into subchondral
bone adjacent to the intervertebral disc of rhesus monkeys
to provide a basis for further in vivo studies on IVD de-
generation. Combined with histology, real-time PCR and
Sulfated Glycosaminoglycans (GAGs) assessment, the T1ρ
magnetic resonance imaging (MRI) technique [11,12],
which has been reported strongly correlated with proteo-




Ten rhesus monkeys (six females and four males), with a
mean age of 5.32 ± 0.47 years old (range, 5–7 years), whichcan be converted to equivalent human age by using a 1:3.5
ratio [13], and a mean body weight of 6.83 ± 0.67 kg
(range, 5.2-7.5 kg) were used in this study. All of the ani-
mals were provided by the center of Guangdong Landao
Biotechnology in Guangzhou of China, and exclude spinal
deformity by radiological examination. The study protocol
was reviewed and approved by the institutional review
board and ethics committee of the First Affiliated Hospital
of our university (No. 2010–204). The animal study was
also approved by the institutional review board and animal
care committee of the First Affiliated Hospital of our uni-
versity (2013A-204).Animal groups
In this study, a single concentration of 1.5 mg/ml bleo-
mycin in phosphate buffered saline (PBS) was performed.
Unlike human beings, there are 7 intervertebral discs
(IVDs) in rhesus monkeys. The subchondral bone adjacent
to the 2 lumbar IVDs (L3/4 and L5/6) were randomly
injected with 4 ml bleomycin solution (Bleomycin, n = 10),
or 4 ml PBS (Control, n = 10), respectively. The degenera-
tive process was investigated by using radiography, T1ρ
MR imaging for 15 months.Experimental surgery
All the experimental surgeries were performed in the
orthopedic research institute of Sun Yat-sen University.
Intramuscular injections of 10 mg/kg ketamine and 0.5 mg/
kg midazolam were used for anesthesia of the monkeys,
followed by 0.3 mg/kg midazolam and 4 μg fentanyl per
hour. Under sterile surgical conditions, the vertebral bodies
from L3 to L6 were exposed by using a left retroperitoneal
approach. After clearly identified, the subchondral bone ad-
jacent to the IVDs of L3-4 and L5-6 was performed accord-
ing to the preoperative design. To induce the subendplate
ischemic model, a hole 1.5 mm in diameter and 15 mm in
depth was drilled in the middle of the intervertebral body
approximately 1.5 mm above and below the disk, followed
by slow injection of 2.0 ml bleomycin (1.5 mg/ml, Tianjin
Taihe Pharmaceutical, Tianjin, People’s Republic of China)
per hole for the belomycin group, and the same volume of
PBS for the control group, respectively. Then, each hole
was sealed with bone wax.
Before, during, and after operation, the monkeys were
given 80 mg per kilogram of ceftriaxone sodium (Baiyun
Pharmaceuticals, Guangzhou, China) subcutaneously. After
operation, the monkeys were housed individually with
free access to water. The rhesus monkeys tolerated general
anesthesia well and no mortalities from complications
caused by anesthesia or infections were found among the
animals. Weight, food intake, and sleeping habits were
recorded.
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The lateral views of roentgenograms for the lumbar spine
were acquired for all the monkeys by using the Digital
Diagnost VM (Philips, Best, the Netherlands), a multipur-
pose single-detector digital radiography system. The aver-
age IVD height was measured manually by an orthopedic
researcher (R. Z.) who was blinded to both the injection
solution used (PBS/Belomycin) and the follow-up period.
The average IVD height was calculated by averaging 3
measurements (Figure 1A). The average IVD height was
obtained concordantly. Subsequently, the average IVD
height was divided by the average caudal vertebral height,
resulting in a value called the disc height index (DHI) lev-
eling out interanimal size difference [14]. Changes in the
DHI were expressed as %DHI and normalized to the mea-
sured preoperative DHI (%DHI = postoperative DHI/pre-
operative DHI × 100%) [15].
MR imaging analysis
Each animal underwent MRI on a 1.5-T MR imager
(Achieva, Philips Healthcare, Best, The Netherlands) with
a supine position on a spine-array coil (5 × 11 inches). The
T1ρ-weighted images were acquired by using spin-lock
pulses followed by a spin-echo acquisition, with time of
spin-lock of 2, 15, 30, and 45 msec and spin-lock fre-
quency of 250 Hz. Using the Siswin software, we mapped
these data and exported the data to mapping images.
Article by Zhou et al. contains details of the T1ρ sequence
[16]. The T1ρ values were calculated on the basis of selec-
tion of the regions of interest (ROIs) [16], which were
manually drawn over the T1ρ maps of the discs by a radi-
ologists (X.P.) with more than 5 years’ experience readingFigure 1 Radiography and T1ρ-weighted images of a part of
the lumbar spine of rhesus monkeys. (A) The Disc Height Index
was calculated by dividing the average disc height (white arrows) by
the average vertebral body height (blasck arrows). (B) An example of
placement of ROIs over NP(#), anterior AF(*) and posterior AF(☆)
was showed in the IVD respectively. ROIs: regions of interest; NP:
nucleus pulposus; AF: annulus fibrosus; IVD: Intervertebral disc.MRI images. ROIs included nucleus pulposus (NP), anter-
ior annulus fibrosus (AF) and posterior AF (Figure 1B).
Values of anterior and posterior AF were averaged as the
value for AF. To evaluate ROIs in a standardized and re-
producible way, we decided to measure oval ROIs (0.1 cm2
on NP, 0.05 cm2 on AF). The average of three mid-sagittal
values from one disk was used for the statistical analysis.
Tissue harvesting
Disc tissues, which involved adjacent endplates, were har-
vested from all the rhesus monkeys under anesthesia with
intramuscular injections of 10 mg/kg ketamine and
0.5 mg/kg midazolam, at 15 months after surgery. All the
specimens were dissected into two halves in the sagittal
plane, one half was fixed for histology analysis, and the
other half was sub-dissected into another two halves,
which were used for messenger RNA (mRNA) analysis
and Sulfated Glycosaminoglycans (GAGs) assessment.
Histology evaluation and histological scores
The specimens were fixed with 4% paraformaldehyde for
24 hours at 4°C, then transferred to a sealed vial con-
taining a solution of 70% ethanol and decalcifying agent
for 30 days. After washed with water, the specimens
were sequentially dehydrated, split down the mid-sagittal
plane, embedded in paraffin for histology sectioning.
Serial sections were cut in the transverse plane at 8 μm
with a microtome (Microtome International, Waldorf,
Germany), and then stained with hematoxylin and eosin
(H&E), masson trichrome or safranin O staining for light
microscopic examination.
The histological changes were qualitatively analyzed by a
pathologist (W.CH.) using a digital image analysis system
(Nikon Eclipse Ti; Nikon, Tokyo, Japan) who was blinded
to the different treatments between groups, according to
the classification scale described by Masuda et al. [4]. The
criteria are summarized in Table 1. The histological score is
the sum of the scores of the 3 individual parameters and
ranged from 3 to 9, where normal is 1point for each of the
3 categories listed above, for a total of 3 points. A total
of 9 points is representative of severe degeneration.
Sulfated Glycosaminoglycans (GAGs) assay
NP from the other half samples were digested using pa-
pain at 65°C for 2 hours. GAG content was calculated in
duplicate by dimethylmethylene blue (DMMB) proced-
ure [17], using chondroitin-4-sulfate (Sigma-27042) as a
standard. The DNA concentration of each sample was
measured using the PicoGreen assay (Molecular Probe)
and used for normalizing the GAG values.
Real-time PCR analysis
Total RNA were extracted from the specimens using Trizol
reagent (Ambion, Carllsbad, CA, USA), followed by the
Table 1 Degeneration histologic grading scale
I Anulus fibrosus
Grade:
1 Normal, pattern of fibrocartilage lamellae without ruptured fibers
and without a serpentine appearance anywhere within the anulus
2 Ruptured or serpentine patterned fibers in less than 30% of the
anulus
3 Ruptured or serpentine patterned fibers in more than 30% of
the anulus





III Cellularity of the nucleus pulposus
Grade:
1 Normal cellularity with large vacuoles in the gelatinous structure
of the matrix
2 Slight decrease in the number of cells and fewer vacuoles
3 Moderate/severe decrease (>50%) in the number of cells and
no vacuoles
Table 2 Sequences of primers used in the real-time PCR
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verse transcription was performed at 42°C for 50 minutes
using the SuperScript First-strand Synthesis Kit (TOYOBO,
Biotech, Co., Ltd., Shanghai, China). Aggrecan, type Icol-
lagen (Col1α1), type IIcollagen (Col2α1), Matrix metallo-
proteinases (MMP)-3, A disintegrin and metalloproteinase
with thrombospondin motifs (ADAMTS)-5, tumor necrosis
factor α (TNFα), interleukin-1β (IL-1β), interleukin-6 ex-
pressions (IL-6), caveolin-1, transforming growth factor-β1
(TGF-β1) and glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) gene expression of the intervertebral discs were
quantified by real-time PCR using CFX96 Real-Time Sys-
tem (Bio-Rad, Herculus, CA, USA). The sequence of all the
primers used for real-time PCR are shown in Table 2. With
a serially-diluted cDNA sample mixture, a positive standard
curve for each primer was obtained for real-time PCR.
Quantitations of gene expression of aggrecan, Col1α1,
Col2α1, MMP-3, ADAMTS-5, TNFα, IL-1β, IL-6, caveolin-
1 and TGF-β1 in the intervertebral discs were calculated
using standard curves and normalized to GAPDH in each
specimen. In order to evaluate the number of capillaries in
the cartilage endplate, the quantitation of gene expression
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above. The experiments were repeated at least twice for
enhanced accuracy.
Statistical analysis
SPSS 16.0 software (SPSS Inc., Chicago, IL) was used for
univariate analysis of variance. The data within groups
were analyzed using One-way Analysis of Variance
(ANOVA) and Fisher’s protected least significant differ-
ence test. The data between groups were compared by
using paired t test. The correlation between the %DHI,
histological score, GAGs content, and T1ρ values of NP
and AF were assessed by the Spearmann rank correlation
test. Data are presented as the mean ± standard deviation.
Statistical significance was indicated at P < 0.05.
Results
No postoperative morbidity or mortality was recorded. All
animals recovered uneventfully after surgery and quickly
resumed normal activities in the cage. None of these ani-
mals showed any remarkable change in weight, eating pat-
terns, or sleeping habits.
Intervertebral disc height
In the control groups, the DHI changes were not signifi-
cant at any time point examined. In contrast, the DHI in
the bleomycin group progressively decreased over time
(Figure 2A), reaching significance when compared with
that in the control group after 12 months (P = 0.02), and
was followed by slowly declining. After 15 months, the
DHI decreased by 12.9%, which was not significant, com-
pared with the DHI at the 12-month time point (P = 0.76).
Histological findings and GAGs assay
The intervertebral discs in the control group appeared
normal. The annulus fibrosus showed normal organizationFigure 2 Mean %DHI, T1ρ values of NP and AF at each time point. (A
postoperatively in the bleomycin group (*P < 0.05). (B) A significant decrea
in the bleomycin group (*P < 0.05), followed by a rapid decrease during th
was observed at 6 months postoperatively in the bleomycin group (*P < 0.
pulposus; AF: annulus fibrosus.of fibrocartilage lamellae (Figure 3A), and the nucleus
pulposus contained abundant cells and sounded by large
zones of acellular matrix (Figure 3B,C). In the bleomycin
group, the discs showed degenerative changes, where the
nucleus pulposus comprised relatively few cells (Figure 3E)
and less proteoglycans (Figure 3F), relative to the control
group. The annulus fibrosus showed less organized fibro-
cartilage lamellae, and the collagen fibers formed a wavy
arrangement (Figure 3D) in the bleomycin group.
The histological score of the discs in the bleomycin
group was significantly higher than the control groups
(P < 0.01, Figure 4A). The total GAG of NP in the bleo-
mycin group decreased significantly compared with the
control group (P < 0.01, Figure 4B).
MRI
The MRI images showed degenerative signs in IVDs
injected with bleomycin (Figure 5). There were no sig-
nificant differences in T1ρ values of NP and AF in the
control group at any time point. In the belomycin group,
the T1ρ values of NP and AF slowly declined after oper-
ation. After 3 months, the decrease in NP was significant
(P = 0.02, Figure 2B). However, the decrease in AF did
not show any significant difference, until 6 months after
operation (Figure 2C). Interestingly, the T1ρ values of
NP showed a rapid decrease during the second 3 months
from 109.3 msec ±10.8 to 82.6 msec ±11.9 (P = 0.003), in
the bleomycin group, and then decreased slowly. After
12 months, both decrease of T1ρ values in NP and AF
tended to be stable.
The correlation of T1ρ values to %DHI, histological
score, or GAGs content was assessed by the Spearman
rank correlation test. Although both of the T1ρ values of
NP and AF negatively correlated with the histological
score, and positively correlated with the total NP GAGs
significantly (P < 0.05, Figure 6, Table 3), the T1ρ values
of AF did so more weakly than that of NP. However, the) A significant decrease of %DHI was observed at 12 months
se in the T1ρ values of NP was observed at 3 months postoperatively
e second 3 months. (C) A significant decrease in the T1ρ values of AF
05), followed by slowly decrease. DHI: Disc height index; NP: nucleus
Figure 3 Hematoxylin and eosin (H&E), masson trichrome and safranin O staining for NP and AF. (A)-(C) The annulus fibrosus showed
normal organization of fibrocartilage lamellae, and the nucleus pulposus contained abundant cells and sounded by large zones of acellular matrix
in the control group. (D)-(F) In the bleomycin group, the nucleus pulposus comprised relatively few cells and less proteoglycans, combined with
less organized fibrocartilage lamellae and a wavy arrangement of collagen fibers, relative to the control group. Black arrows indicate notochordal
cells based on morphology.
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the %DHI was much stronger than that of NP (Table 3).
Real-time PCR
The expression of Aggrecan and Col2α1 were significantly
lower, and the expression of MMP-3, ADAMTS-5, TNF-α,
IL-1β, IL-6 and TGF-β1 were significantly upregulated in
the bleomycin group as compared with the control group
(P < 0.05, Figure 7). The expression of vWF in the bleo-
mycin group significantly decreased in comparison with the
control groups (P < 0.05, Figure 7). However, there were no
significant differences in the expression of Col1α1 and
caveolin-1 between groups (P > 0.05, Figure 7).
Discussion
It has been generally recognized that degenerative disc
disease is the most common cause of low back pain.
Recently, biological therapies for early intervention of de-
generative disc disease have been introduced and devel-
oped, including direct delivery of specific growth factors,
plate-rich plasma, adenovirus particles or autologous cells,
into the disc [18-20]. Thus, it is essential to establish a
suitable disc degenerative model that could better model
the human disease process to evaluate the novel treatment
options. However, to our known, there are no particular
models currently parallel the complex nature of human disc
degeneration [17,21]. In the present study, we designed a
new method of inducing an IVD degeneration model in the
rhesus monkey and have demonstrated that it could induce
slowly progressive and mild disc degeneration, which mim-
icked the onset of human disc degeneration.
It is known that the nutrient exchange for disc cells is
mostly from the capillaries of the subchondral plate of the
vertebral body, across the layers of hyaline cartilage thatconstitute the endplate [22]. Disorders that affect the
blood supply to the endplate are significantly associated
with disc degeneration and back pain [23]. In our study,
we injected bleomycin,which could produce a “devascular
effect” [8,9], into the subchondral bone adjacent to the
IVDs of rhesus monkeys. The results of quantitative T1ρ
MR imaging showed that the T1ρ values of nucleus pulpo-
sus and annulus fibrosus decreased slowly after surgery,
compared with the control group. The degenerative signs
of this model developed slower, compared with other ani-
mal models, such as needle puncture models or chem-
ically induced models, which were reported to degenerate
significantly within 2 to 4 weeks [21]. However, as disc de-
generation develops in several decades in humans, the
slow development of the degeneration in the rhesus model
is relative. In this study, another interesting finding was
that, the results showed a great decrease in T1ρ values of
NP in the second 3 months after surgery. This was similar
to the degenerative process of human subjects, which had
also showed a rapid decrease in T1ρ values between Pfirr-
man gradesIIand III reported by Zhou et al. [16]. This, to
some extent, suggested that the degenerative process of
this model may be a better surrogate used for investigation
of early stage disc degeneration and regeneration studies.
The histomorphological findings and GAGs assay showed
that the GAGs in nucleus pulposus decreased significantly
in the bleomycin group. These changes were consistent
with the previous studies showing loss of proteoglycans
during the initial phase of disc degeneration [24]. In human
discs, the notochordal cells (NCs) are lost during adoles-
cence, which is also when discs begin to show degenerative
signs [25]. Although the cell population significantly de-
creased in nucleus pulposus of this degenerative model of
rhesus monkeys, notochordal cells were still observed. This
Figure 5 The representative T1ρ maps of lumbar spine in an rhesus m
L5-6 respectively. Preop: Preoperatively.
Figure 4 Bar graphs illustrating histological score and total NP
GAGs between groups. (A) The histological score of the discs in
the bleomycin group was significantly higher than the control
groups (#P < 0.01). (B) The total GAG of NP in the bleomycin group
decreased significantly compared with the control group (#P < 0.01).
GAGs: Glycosaminoglycans; NP: nucleus pulposus.
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this limits relevance to humans, these changes in the de-
generative model of this study confirmed that injection
of bleomycin into the subchondral bone adjacent IVD of
rhesus monkeys could induce early disc degeneration,
which showed some similar characteristic features to the
complex processes of disc degeneration in human, such as
disc height loss, significant decrease of cell population and
glycosaminoglycans in the nucleus pulposus, and less orga-
nized fibrocartilage lamellae in the annulus fibrosus, et al.
As previously reported, the histological scale and radio-
graphic findings for assessing IVD degeneration showed a
consistency to MRI evaluation [4]. In this study, with
Sperman rank correlation coefficient of −0.761 and −0.729
(P < 0.01), the correlation between the histological
scores and the T1ρ values of NP and AF are significant.
Although the correlation between the %DHI and the T1ρ
values of NP and AF are also significant, but not so strong.
This may be due to the different sensitivity of histological
and disc height analyses in response to disc degeneration.
Early disc degeneration with a slight loss of nucleus pulpo-
sus that may be easily detected by histology, may not show
significant differences in the disc height change, which is
largely affected by the structural changes. It has been re-
ported that T1ρ MRI imaging is strongly correlated with
proteoglycan content [11,12]. This is also observed in our
study, which showed strong correlation between the total
NP GAGs and the T1ρ values of NP and AF.
It has been revealed that proteoglycans has the ability to
bind to collagen, growth factors, and other matrix compo-
nents [26]. In this study, it has been shown that the col-
lagenIIexpression in the discs of bleomycin group was
reduced compared with that in the control group, which
was consistent with the theory that proteoglycans can bind
to collagens. The degenerative changes in the IVDs, such
as composition of extracellular matrix (ECM), loss of disc
cells, proteoglycan and water content, have been suggested
to be the consequence of an up-regulation of catabolic
MMPs and two major aggrecanases, ADAMTS-4 and 5
[27,28]. Consistent with the previous reports [27,28], we
found that mRNA expression of MMP-3 and ADAMTS-5
were significantly increased in the discs of bleomycinonkey model. Bleomycin and PBS solution was injected at L3-4 and
Figure 6 Correlations of T1ρ values to %DHI, histological score, and total NP GAGs. (A)-(B) A mild correlation was observed between %DHI
and T1ρ values of NP and AF(P < 0.01). (C)-(D) A strong inverse correlation was found between histological score and T1ρ values of NP and
AF(P < 0.01). (E)-(F) The total NP GAGs change correlated significantly with the T1ρ values of NP(P < 0.01), wheares the T1ρ values of AF did so
more weakly than that of NP(P < 0.05).
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to the abnormal nutrient transport between the IVD
and endplates due to the “devascular effect” of bleomycin,
which was confirmed by the mRNA expression of vWF in
the bone endplates.
It has been reported that the cytokines TNF-α, IL-1β,
IL-6 and IL-8 increased significantly in aged and/or
degenerated IVDs [29-31]. In this study, there were
significant increase of the gene expression of TNF-α,
IL-1β and IL-6 in the IVD of bleomycin group. It has
been confirmed that hypoxia could increases oxidative
stress in several cell types [32,33], including the noto-
chordal intervertebral disc cells [34]. In this study, the
nutrition exchange of the IVD was disturbed by injec-
tion of bleomycin into the subchondral bone adjacent
to the IVDs of rhesus monkeys. This could disturb
the oxygen supply to the IVDs, and then induced in-
creasing oxidative stress, which might account for theTable 3 The correlation among disc height index,
histological score, total NP GAGs and T1ρ values
(Sperman rank correlation coefficient, rho)
% DHI Histological score Total NP GAGs
T1ρ values of NP 0.601 −0.761 0.740
P < 0.0001 P < 0.0001 P < 0.0001
T1ρ values of AF 0.630 −0.729 0.582
P < 0.0001 P = 0.0003 P = 0.02
NP = nucleus pulposus; AF = annulus fibrosus; % DHI = change in disc
height index.
GAGs = glycosaminoglycans.increasing gene expression of inflammatory cytokines
in the IVDs.
TGF-β is a multifunctional regulator of cellular prolif-
eration, differentiation, and extracellular matrix (ECM)
production. Thompson et al. [35] reported the anabolic
effect of TGF-β on proteoglycans (PGs) synthesis in
canine disc cells. Lee et al. [36] found that the level of
TGF-β was higher in patients with disc degenerativeFigure 7 mRNA expression of genes at 15 months postoperatively.
This graph showed a lower expression of aggrecan, Col2α1 and
caveolin-1, and a significant upregulation of MMP-3, ADAMTS-5, TNF-α,
IL-1β, IL-6 and TGF-β1 in the bleomycin group as compared with the
control group (P < 0.05). The expression of vWF in the bleomycin group
significantly decreased in comparison with the control group (P < 0.05).
#P < 0.05 vs the control group.
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overexpression of TGF-β showed deleterious effect on
degenerated cartilage tissue via increase of aggrecanase-
1 and MMP-13 [37,38]. In this study, the gene expres-
sion of TGF-β was more higher in the degenerative
discs, which was consistent with the previous reports
[35,36]. Caveolin-1, which is a scaffold protein of caveo-
lae, is elevated in degenerative discs and has been pro-
posed to play a prominent role in the pathogenesis of
IVD degeneration [39]. However, Smolder et al. [40]
found that IVD degeneration involved significant down-
regulation in caveolin-1. In this study, the gene expres-
sion of caveolin-1 was down-regulated in the degenerative
discs. This may be due to the effect of bleomycin, which
can lead to caveolin-1 down-regulation in fibrosing lung
[41]. No matter what reason it is, however, further stud-
ies are warranted to evaluate the role of caveolin-1 in
disc degenerative disease.
In our study, rhesus monkeys, higher in the phylo-
genetic tree, were used because of the similarities of
their anatomic and physiological characteristics, and
IVD anatomy similar to that of humans [42]. Thus, this
ischemic degenerative model in the present study
could better simulate the IVD degeneration of humans.
However, this study also has some limitations. We did
not perform the histological evaluation during the fol-
low up period, due to the high cost and limited num-
ber of animals. Another limitation was that we did not
perform the biomechanical evaluation, such as hydro-
static pressure in the degenerative discs. Additional
studies are warranted to further evaluate the mechan-
ism and characters of disc degeneration induced by
bleomycin.
Conclusions
This current study demonstrate that the injection of bleo-
mycin into the subchondral bone adjacent to the lumbar
IVDs of rhesus monkeys can induce slowly progressive
and mild disc degeneration, which mimics the onset of
human disc degeneration. T1ρ MR imaging is an effective
and noninvasive technique for assessment of disc degener-
ation. The degeneration model is suitable for disc degener-
ation and regeneration studies. Further studies to fully
establish this model, however, are needed.
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